Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies
Geoffrey A Pietersz, Xiaowei Wang, May Lin Yap, Bock Lim, Karlheinz Peter
Nanomedicine | FUTURE MEDICINE LTD | Published : 2017
K Peter was supported by a Principal Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.